全文获取类型
收费全文 | 967篇 |
免费 | 24篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 46篇 |
妇产科学 | 13篇 |
基础医学 | 75篇 |
口腔科学 | 17篇 |
临床医学 | 130篇 |
内科学 | 238篇 |
皮肤病学 | 34篇 |
神经病学 | 25篇 |
特种医学 | 257篇 |
外科学 | 44篇 |
综合类 | 28篇 |
预防医学 | 51篇 |
眼科学 | 22篇 |
药学 | 44篇 |
中国医学 | 3篇 |
肿瘤学 | 38篇 |
出版年
2023年 | 5篇 |
2022年 | 3篇 |
2020年 | 4篇 |
2019年 | 7篇 |
2018年 | 7篇 |
2017年 | 4篇 |
2016年 | 9篇 |
2015年 | 12篇 |
2014年 | 16篇 |
2013年 | 15篇 |
2012年 | 14篇 |
2011年 | 16篇 |
2010年 | 32篇 |
2009年 | 51篇 |
2008年 | 15篇 |
2007年 | 51篇 |
2006年 | 19篇 |
2005年 | 21篇 |
2004年 | 11篇 |
2003年 | 14篇 |
2002年 | 13篇 |
2001年 | 19篇 |
2000年 | 22篇 |
1999年 | 9篇 |
1998年 | 82篇 |
1997年 | 70篇 |
1996年 | 59篇 |
1995年 | 51篇 |
1994年 | 43篇 |
1993年 | 44篇 |
1992年 | 21篇 |
1991年 | 15篇 |
1990年 | 24篇 |
1989年 | 34篇 |
1988年 | 34篇 |
1987年 | 26篇 |
1986年 | 22篇 |
1985年 | 23篇 |
1984年 | 18篇 |
1983年 | 11篇 |
1982年 | 17篇 |
1981年 | 9篇 |
1980年 | 13篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 16篇 |
1976年 | 13篇 |
1975年 | 13篇 |
1958年 | 2篇 |
1900年 | 2篇 |
排序方式: 共有1066条查询结果,搜索用时 15 毫秒
81.
Time-dependent loss of surface complement regulatory activity during storage of donor blood 总被引:2,自引:0,他引:2
The survival of transfused red cells (RBCs) diminishes with time of in vitro storage in blood banks, but the molecular mechanisms underlying the slow but incessant deterioration are incompletely understood. To investigate the possibility that impaired resistance to autologous complement attack could play a role in this phenomenon, packed RBCs stored for variable periods were assayed for decay-accelerating factor (DAF) and CD59, two glycoinositol-phospholipid (GPI)-anchored, membrane- associated complement regulatory proteins that function physiologically to protect blood cells from autologous complement activation on their surfaces. Immunoradiometric and flow cytometric assays employing DAF and CD59 monoclonal antibodies showed that levels of both surface proteins gradually declined over 6 weeks. Digestion analyses with phosphatidylinositol-specific phospholipase C, an enzyme that releases GPI-anchored proteins from cell surfaces, showed that DAF and CD59 molecules with GPI anchors containing unacylated inositol were preferentially lost. These findings suggest: 1) that DAF and CD59 molecules with acylated GPI anchors are more stable in RBC membranes than are molecules with unacylated GPI anchors, and 2) that DAF and CD59 loss may participate with other membrane alterations that occur during in vitro storage in compromising the survival of transfused cells. 相似文献
82.
张建军 《中国组织工程研究与临床康复》2007,11(31):6228-6232
目的:观察微囊化转大鼠脑啡肽原基因(pENK)细胞移植对慢性脊神经压榨性损伤大鼠的镇痛效应.
方法:实验于2006-03/2007-04在郑州大学医学重点实验室完成.①实验方法:通过反转录-聚合酶链反应技术可获得大鼠pENK基因,Hind Ⅲ,ClaⅠ双酶切后,同相应双酶切的pLNCX2载体大片段连接,构建成pENK基因反转录病毒载体pLNCX2-Enk,然后用脂质体法将该载体转染PT67细胞,G418筛选,获得携带pENK基因高滴度反转录病毒产毒细胞系.用海藻酸钠-多聚赖氨酸-海藻酸钠微囊包埋后,进行体外培养,定期检测微囊化细胞活性和pENK分泌量变化.同时,将转基因细胞移植于慢性脊神经压榨性损伤大鼠的蛛网膜下腔.②实验分组:SD大鼠60只,其中53只按照Bennett和Xie法制作大鼠慢性左侧坐骨神经压迫性损伤模型,其中42只造模成功.术后1周,将动物按随机数字表法分为3组,每组16只:微囊化转基因细胞移植组、空囊移植组和阴性对照组.微囊化转基因细胞移植组、空囊移植组分别植入微囊化细胞悬液80 μL(约300个微囊)、空微囊悬液80 μL(约300个空囊),阴性对照组不注射任何悬液.③实验评估:术后2周和8周行甲醛实验,在大鼠一侧后爪掌侧皮下注射体积分数为0.05的甲醛50 μL,观察其注射后1 h内的痛反应.采用Abbott等所推荐的以缩腿及舔爪时间之和作为行为学反应的指标.注射甲醛后,立即记录大鼠1 h内每5 min的缩腿及舔爪时间.
结果:①术后2周甲醛实验:空囊移植组第一时相的急性痛阶段(注射后5 min)和第二时相的慢性痛阶段(注射后41~45 min)大鼠的缩腿及舔爪时间都少于微囊化转基因细胞移植组(P<0.01).而在静息期,3组大鼠的缩腿及舔爪时间差异无显著性意义(P>0.05).②术后8周甲醛实验:3组大鼠的痛觉行为都呈明显的双时相反应.除了静息期(注射后5~15 min),微囊化转基因细胞移植组在各时间点上大鼠的缩腿及舔爪时间均低于空囊移植组(P<0.05).微囊化转基因细胞移植组大鼠的缩腿及舔爪时间在第一时相的急性痛阶段和第二时相的慢性痛阶段都低于空囊移植组(P<0.05).
结论:微囊化转pENK基因细胞移植对慢性神经痛大鼠有一定的镇痛作用,有望成为运动员慢性疼痛治疗的新方法. 相似文献
83.
JJ Korelitz ; AE Williams ; MP Busch ; TF Zuck ; HE Ownby ; LJ Matijas ; DJ Wright 《Transfusion》1994,34(10):870-876
BACKGROUND: Most blood centers utilize a confidential unit exclusion (CUE) process, intended to reduce the risk of transfusion-associated infectious diseases by allowing high-risk donors confidentially to exclude their blood from use for transfusion. The effectiveness of this method remains controversial. STUDY DESIGN AND METHODS: Confirmatory or supplemental test results for antibodies to human immunodeficiency virus, human T-lymphotropic virus type I, and hepatitis C virus, as well as hepatitis B surface antigen and syphilis and screening test results for antibodies to hepatitis B core (antigen) and alanine aminotransferase levels were obtained for approximately 1.8 million units donated during 1991 and 1992 at five blood centers within the United States. The prevalences of these infectious disease markers in units that the donors confidentially excluded (CUE+) and units that the donors did not exclude (CUE-) were calculated and examined within demographic subgroups. RESULTS: Units that were CUE+ were 8 to 41 times more likely to be seropositive for antibodies to human immunodeficiency virus and hepatitis C virus, hepatitis B surface antigen, and syphilis and three to four times more likely to react for antibody to hepatitis B core (antigen) or to have elevated alanine aminotransferase levels than units that were CUE- (p < 0.001). The positive predictive value of CUE (the percentage of CUE+ units that were confirmed seropositive for any marker) was 3.5 percent, and the sensitivity of CUE (the percentage of confirmed-seropositive units that were CUE+) was 2.3 percent. CONCLUSION: The current CUE process has low sensitivity and apparently low positive predictive value, and in many cases, it appeared that donors misunderstood it. Yet, CUE was not a “random process,” as CUE+ units were more likely to be seropositive for any infectious disease marker than CUE- units. This suggests that efforts to improve the CUE system may be warranted. As risk factors for transfusion-transmitted infection become more difficult to identify by history-based screening, however, such efforts may have limited effect. 相似文献
84.
Uemichi T; Liepnieks JJ; Alexander F; Benson MD 《QJM : monthly journal of the Association of Physicians》1996,89(10):745-750
Hereditary amyloidosis of an unusual form has been reported in two separate
kindreds; one was Polish-Canadian and the other was Irish- American (Am J
Med 1975; 59:121 and Trans Assoc Am Physicians 1981; 94:211). In both
kindreds, affected members developed hypertension and nephrotic syndrome
due to amyloidosis in their forties or fifties, but the genetic background
responsible for the condition has been left undetermined. To identify the
genetic defect in these kindreds, a portion of exon 5 of the fibrinogen
alpha-chain gene in members of these kindreds was examined for a mutation
by single-strand conformation polymorphism analysis and direct DNA
sequencing. DNA analyses revealed an A-->T transversion at the second
base of codon 526 of the fibrinogen alpha-chain gene in both of these
kindreds. Analysis of DNA polymorphisms in the fibrinogen alpha-chain gene
locus (TCTT repeat in intron 3, Rsal site in exon 5, and Taql site in the
3' flanking region of the gene) showed the haplotype B5-Rsal(+)-Taql(-) for
the Val 526 mutant gene in both kindreds studied here, as well as in two
kindreds previously described (J Clin Invest 1994; 93:731). The fibrinogen
alpha-chain gene mutation (Val 526) is the genetic defect responsible for
hereditary renal amyloidosis in these two kindreds, and the mutant genes in
the Val 526 kindreds may have been derived from a single founder.
相似文献
85.
Background
Management of high-grade T1 (formerly T1G3) bladder cancer continues to be controversial. Should patients with T1G3 bladder cancer have an immediate radical cystectomy or should they receive intravesical bacillus Calmette-Guérin preserving bladder? Gemcitabine and cisplatin (GC) adjuvant chemotherapy may help to strike a balance between intravesical and early cystectomy. For purposes of this study, we continue to refer high-grade T1 lesion as “T1G3.”Objective
To evaluate the characteristics and the long-term outcome of GC adjuvant chemotherapy in T1G3 bladder cancer after transurethral resection of bladder tumor (TURBT).Materials and methods
We, retrospectively, reviewed 48 patients who were newly diagnosed with T1G3 bladder cancer between January 2009 and December 2012. A total of 48 patients received 4 cycles of GC adjuvant chemotherapy after TURBT. One month after 4 cycles of GC adjuvant chemotherapy, response was evaluated by re-TURBT. Median follow-up was 59.5 (range: 18–70) months, all patients have been observed for more than 3 years. Salvage cystectomy was recommended for patients with persistent disease and for tumor progression after initial complete response.Result
Complete response was achieved in 44 (91.7%) patients. Of complete responders, 5 patients experienced recurrence and 5 patients showed progression. The progression rate and disease-specific survival rate were 10.4% and 91.7% at 3 years, respectively. More than 80% of survivors preserved their bladder. Kaplan-Meier curves showed that concomitant carcinoma in situ (CIS) was the only factor that had an influence on progression-free survival (P = 0.022) and disease-specific survival (P = 0.017). Concomitant CIS was the prognostic factor for progression rate and disease-specific survival rate at 3 years (P = 0.008 and P = 0.035).Conclusion
GC adjuvant chemotherapy is a safe conservative treatment for T1G3 bladder cancer, but effective is really a phase II study. Patients with T1G3 bladder cancer with concomitant CIS should be treated more aggressively because of the high risk of progression. 相似文献86.
胶原海绵复合新生大鼠原代心肌细胞构建工程化心肌组织 总被引:2,自引:2,他引:2
目的:探索以胶原海绵为支架、新生大鼠原代心肌细胞为种子细胞,于体外构建工程化心肌组织的方法。方法:实验于2005-12/2006-11在解放军第四军医大学西京医院心内科实验室完成。Ⅰ型胶原海绵剪切成方形片状(2.0cm×1.4cm×0.2cm),经60Co照射消毒,于DMEM培养液中水化1h左右。另取1d龄SD大鼠心脏,剪成小碎块,然后用2.5g/L胰蛋白酶于37℃中消化,吸取上清至含胎牛血清的DMEM中,重复消化四五次,用差速贴壁法除去大部分成纤维细胞,将细胞沉淀用DMEM培养液以2×109L-1的密度悬浮备用。将上述的心肌细胞悬液1mL缓慢滴注于玻璃模型中的胶原海绵上,然后置于细胞培养中培养。肉眼及显微镜主要观察工程化心肌组织在培养期间的自发收缩情况,包括收缩的部位、强度、频率、一致性以及收缩随时间变化的情况。苏木精-伊红染色观察工程化心肌组织内胶原纤维的变化,细胞形态,胞核的形状及细胞之间的连接。免疫组织化学染色和透射电镜观察工程化心肌组织片的形态和功能。结果:①细胞接种于胶原海绵上1d后,细胞/胶原复合物的凝胶化过程基本完毕,体积保持恒定,维持至培养结束,第3天细胞/胶原复合物局部出现点片状自发收缩,第5天整个细胞/胶原复合物出现同步化自发收缩,收缩频率61~199次/min。2周后37.5%的工程化心肌组织的自发收缩活动减弱,但75%的工程化心肌组织的自发收缩活动持续至培养结束。②苏木精-伊红染色、免疫组织化学染色和透射电子显微镜显示,工程化心肌组织内细胞间连接广泛存在,细胞多呈纵向分布,胞核呈长圆形,胞浆内α-肌节肌动蛋白阳性,胞内肌原纤维排列整齐,可见到心肌特异性的肌小节结构和Z线,多数细胞具有分化的心肌细胞表型。结论:用新生大鼠原代心肌细胞为种子细胞、以Ⅰ型胶原海绵为支架材料,构建出的工程化心肌组织,于体外可长时间持续自发收缩,该细胞/胶原复合物的形态结构与生理功能均类似于成熟大鼠心肌组织。 相似文献
87.
目的:介绍言语流畅性的测量工具,考察言语流畅性与记忆之间的关系,探讨言语流畅性的神经生理基础。资料来源:应用计算机检索Sciencedirect 1975-07/2005-05中与言语流畅性相关的文献,检索词为“verbal fluency”,限定文章语言种类为英文。资料选择:对资料进行初审,选取文章标题中含有“verbal fluency”的英文文献。纳入标准:①对言语流畅性测量任务的研究。②对言语流畅性与记忆的研究。③对言语流畅性神经生理基础的研究。资料提炼:共收集到651篇关于言语流畅性的文章,纳入30篇用于本综述。资料综合:测量言语流畅性的任务主要分为简单任务(包括音位流畅性任务和语义流畅性任务)与复杂任务(包括可能工作、替代使用、草拟、推断、物品制作以及新的使用方法等)。言语流畅性任务的完成主要涉及到记忆搜索的过程,另外,精细组织的语义网络系统对于言语流畅性任务来说也是非常重要的。言语流畅性的神经生理基础包括了总体基础,前额叶,海马以及大脑两半球的不对称性。结论:言语流畅性作为人类语言基本技能的一项指标,对语言认知研究具有极其重要的意义。它不仅是神经心理研究的一项非常重要的检测和诊断指标,也是一种研究人类心理的非常有用的研究工具,是探索人类语言与认知、创造之迷进而探索人类意识之迷的钥匙。 相似文献
88.
The mouse monoclonal antibody M2A1 of IgG1 class, which is highly specific for blood group M antigen, was obtained and characterized by means of hemagglutination, enzyme-linked immunosorbent assay, immunoblotting, and inhibition assays. The use of modified M glycoprotein preparations for inhibition tests and of variant McN and Henshaw red cell membranes for immunoblotting showed that M2A1 recognized an epitope including the NH2-terminal serine and sialic acid residues of glycophorin A, whereas the fifth glycine residue was not involved. The reactivity of the antibody with M antigen was distinctly dependent on ionic strength and pH; the optimum was at pH 8 to 9. The alpha-amino group of terminal serine residue was not necessary for the reaction with M2A1 antibody, and the results obtained suggested that the positive charge of this group contributed to decreasing antigen-antibody reactions at pH below 8. The reaction of the antibody with blood group N antigen was not detectable in any of the assays used. 相似文献
89.
Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid 总被引:9,自引:0,他引:9
Ward M; McNulty H; McPartlin J; Strain JJ; Weir DG; Scott JM 《QJM : monthly journal of the Association of Physicians》1997,90(8):519-524
Elevated plasma homocysteine, an independent risk factor for cardiovascular
disease (CVD) can be lowered by administration of pharmacological doses of
folic acid. The effect of lower doses in apparently normal subjects is
currently unknown but is highly relevant to the question of food
fortification. Healthy male volunteers (n = 30) participated in a chronic
intervention study (26 weeks). Folic acid supplements were administered
daily at doses increasing from 100 micrograms (6 weeks), to 200 micrograms
(6 weeks), to 400 micrograms (14 weeks). Fasting blood samples collected
before, during and 10 weeks post intervention were analysed for plasma
homocysteine, serum and red- cell folate levels. Results, expressed as
tertiles of baseline plasma homocysteine concentration, showed significant
(p < or = 0.001) homocysteine lowering in the top (10.90 +/- 0.83
mumol/l) and middle (9.11 +/- 0.49 mumol/l) tertiles only. In the low
tertile, where the mean baseline homocysteine level was 7.07 +/- 0.84
mumol/l, no significant response was observed. Of the three folic acid
doses, 200 micrograms appeared to be as effective as 400 micrograms, while
100 micrograms was clearly not optimal. There is thus a minimal level of
plasma homocysteine below which folic acid has no further lowering effect,
probably because an optimal folate status has been reached. A dose as low
as 200 micrograms/day of folic acid is effective in lowering plasma
homocysteine concentrations in apparently normal subjects. Any public
health programme for lowering homocysteine levels, with the goal of
diminishing CVD risk, should not be based on unnecessarily high doses of
folic acid.
相似文献
90.
The efficacy of subcutaneous recombinant human erythropoietin (rhEPO) (500 U/kg; administered twice a week during the 3 weeks before surgery) in the recovery of preoperative hemoglobin concentrations within a 3- week period was studied in 40 patients, each of whom donated 2 units (900 mL) of blood for their own use before total hip replacement surgery. Twenty autologous blood donors received rhEPO (EPO group) and 20 were not treated (control group). The initial hemoglobin concentration (14.0 +/− 1.0 g/dL [140 +/− 10 g/L]) was completely recovered before surgery (14.0 +/− 1.6 g/dL [140 +/− 16 g/L]) in the EPO group, while a decrease from 13.8 +/− 1.1 to 12.2 +/− 1.3 g per dL (138 +/− 11 to 122 +/− 13 g/L) was observed in the control group. The preoperative reticulocyte count showed more than sixfold increase in the EPO group, whereas a twofold to threefold increase was found in the control group. Serum ferritin concentration fell to 42 +/− 29 micrograms per L in the EPO group and to 54 +/− 35 micrograms per L in the control group. The postoperative serum erythropoietin concentration in the EPO group was significantly lower than that in the control group, but it did not differ from the pretreatment value and was attended by a higher hemoglobin concentration after surgery. Only transient flu-like symptoms were mentioned by patients who were treated with rhEPO. Changes in blood pressure or platelet count or other adverse events were not observed.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献